---

This issue brief details how Germany keeps medication costs low through centralized drug assessment, price negotiations, and price ceilings for noninnovative therapies – all with only modest government involvement. Insurers, providers, and patient advocacy groups all play key roles in the country’s drug pricing system.
       

Source: The Commonwealth Fund: Publications - January 24, 2020 Category: International Medicine & Public Health Authors: James C. Robinson, Patricia Ex, Dimitra Panteli Source Type: research